Longboard Stock Analysis

LBPH -  USA Stock  

USD 8.62  0.73  7.81%

The big decline in price over the last few months for Longboard Pharmaceuticalsmay encourage stockholders to take a closer look at the firm as it is trading at a share price of 8.62 on very low momentum in trading volume. The company executives failed to add value to investors and positioning the firm supply of money to exploit market volatility in May. However, diversifying your holdings with Longboard Pharmaceuticals or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 6.04. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Longboard Pharmaceuticals partners.
Additionally, see Stocks Correlation.

Search Stock Analysis 

The Longboard Pharmaceuticals stock analysis report makes it easy to digest most publicly released information about Longboard Pharmaceuticals and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Longboard stock analysis module also helps to analyze the Longboard Pharmaceuticals price relationship with some important fundamental indicators such as market cap and management efficiency.

Longboard Stock Analysis Notes

The company had not issued any dividends in recent years. Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines for neurological diseases. The company was founded in 2020 and is based in San Diego, California. Longboard Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people. To find out more about Longboard Pharmaceuticals contact the company at 619 592 9775 or learn more at http://www.longboardpharma.com.

Longboard Pharmaceuticals Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Longboard Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Longboard Pharmaceuticals or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Longboard Pharmaceuticals generates negative expected return over the last 90 days
Longboard Pharmaceuticals has high historical volatility and very poor performance
Longboard Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (14.4 M).
Longboard Pharmaceuticals currently holds about 55.32 M in cash with (3.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 14.4, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Longboard Pharmaceuticals has a very weak financial position based on the latest SEC disclosures
Latest headline from www.equities.com: Longboard Pharmaceuticals Inc gains 4.9140 percent for June 16 - Equities.com

Longboard Largest EPS Surprises

Earnings surprises can significantly impact Longboard Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Longboard Pharmaceuticals SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Longboard Pharmaceuticals prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Longboard Pharmaceuticals investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Longboard Pharmaceuticals specific information freely available to individual and institutional investors to make a timely investment decision.
10th of May 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
12th of April 2021
Unclassified Corporate Event
26th of March 2021
Unclassified Corporate Event
24th of March 2021
Unclassified Corporate Event
22nd of March 2021
Unclassified Corporate Event

Longboard Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Longboard Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Longboard Pharmaceuticals backward and forwards among themselves. Longboard Pharmaceuticals' institutional investor refers to the entity that pools money to purchase Longboard Pharmaceuticals' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Cormorant Asset Management LpCommon Shares2.4 M37.2 M
Price T Rowe Associates IncCommon Shares2.3 M36.2 M
Fmr LlcCommon SharesM32.5 M
Farallon Capital Management LlcCommon Shares810.5 K13.3 M
Citigroup IncCommon Shares405.6 K6.6 M
Orbimed Advisors LlcCommon Shares300 K4.9 M
Millennium Management LlcCommon Shares190.3 K3.1 M
Note, although Longboard Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Longboard Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 274.9 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Longboard Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Longboard Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The current Total Assets is estimated to decrease to about 50.3 M. The current Current Assets is estimated to decrease to about 49.5 MLongboard Pharmaceuticals management efficiency ratios could be used to measure how well longboard pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for 2021
Book Value per Share(0.64) (0.69) 
Tangible Assets Book Value per Share 13.29  13.22 
Tangible Asset Value50.6 M50.3 M

Technical Drivers

As of the 19th of June, Longboard Pharmaceuticals secures the mean deviation of 4.26, and Risk Adjusted Performance of (0.07). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Longboard Pharmaceuticals, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Longboard Pharmaceuticals, which can be compared to its peers in the industry. Please verify Longboard Pharmaceuticals treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Longboard Pharmaceuticals is priced some-what accurately, providing market reflects its recent price of 8.62 per share. Given that Longboard Pharmaceuticals has jensen alpha of (0.82), we recommend you to check Longboard Pharmaceuticals's last-minute market performance to make sure the company can sustain itself at a future point.

Longboard Pharmaceuticals Price Movement Analysis

The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. View also all equity analysis or get more info about mavp overlap studies indicator.

Longboard Pharmaceuticals Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Longboard Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Longboard Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Longboard Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Longboard Pharmaceuticals Technical and Predictive Indicators

Longboard Pharmaceuticals Forecast Models

Longboard Pharmaceuticals time-series forecasting models is one of many Longboard Pharmaceuticals' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Longboard Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Longboard Pharmaceuticals Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Longboard Pharmaceuticals stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Longboard shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Longboard Pharmaceuticals. By using and applying Longboard Stock analysis, traders can create a robust methodology for identifying Longboard entry and exit points for their positions.
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines for neurological diseases. The company was founded in 2020 and is based in San Diego, California. Longboard Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people.

Current Longboard Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Longboard analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Longboard analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
32.75Strong Buy4Odds
Longboard Pharmaceuticals current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Longboard analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Longboard stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Longboard Pharmaceuticals, talking to its executives and customers, or listening to Longboard conference calls.
Longboard Analyst Advice Details

Longboard Stock Analysis Indicators

Longboard Pharmaceuticals stock analysis indicators help investors evaluate how Longboard Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Longboard Pharmaceuticals shares will generate the highest return on investment. By understating and applying Longboard Pharmaceuticals stock analysis, traders can identify Longboard Pharmaceuticals position entry and exit signals to maximize returns.
Quick Ratio17.65
Fifty Two Week Low15.50
Fifty Two Week High17.60
Average Daily Volume Last 10 Day495.24k
Average Daily Volume In Three Month495.24k
Fifty Day Average16.41
Two Hundred Day Average16.41
Additionally, see Stocks Correlation. Note that the Longboard Pharmaceuticals information on this page should be used as a complementary analysis to other Longboard Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Search module to search for activelly-traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Longboard Pharmaceuticals Stock analysis

When running Longboard Pharmaceuticals price analysis, check to measure Longboard Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Longboard Pharmaceuticals is operating at the current time. Most of Longboard Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Longboard Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Longboard Pharmaceuticals' price. Additionally, you may evaluate how the addition of Longboard Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Search
Search for activelly-traded equities including funds and ETFs from over 30 global markets
The market value of Longboard Pharmaceuticals is measured differently than its book value, which is the value of Longboard that is recorded on the company's balance sheet. Investors also form their own opinion of Longboard Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Longboard Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Longboard Pharmaceuticals' market value can be influenced by many factors that don't directly affect Longboard Pharmaceuticals underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Longboard Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Longboard Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Longboard Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.